While circular RNA platforms can enhance protein expression, developing effective delivery strategies remains the key challenge to achieving therapeutic efficacy.
- Crossing The Brain's Barrier: Recent Advances And What Lies Ahead
- Navigating Combination Products: Device Complexity And Software Integration
- Improving Execution Of Biological Evaluation Of Drug Delivery Devices
- DDW 2026 Signalled The Next Era Of Competitive Landscape In IBD
- From Exosomes To Nanodrugs: Advancing Therapeutic Delivery For CNS Repair
- Risk Is the Spine: What The First 100 QMSR Inspections Reveal
- Advancing Autologous Stem Cell Engineering For Diabetes And Vision Loss
- The Hidden Operational Complexities Of Home Infusion
ON-DEMAND WEBINARS
Discover how to advance new compounds with complex chemistry through each stage of development by refining processes to give fit-for-purpose manufacturability and yields.
Succeed in combination product development by understanding the risk factors that may arise and implementing mitigation strategies that will streamline the device development process.
Explore how PEG selection shapes drug development success by understanding the benefits of expert CDMO partnerships that deliver custom solutions to enhance your small molecule program.
Gain confidence in your container closure system selection by utilizing a stepwise and data-driven approach to predicting and verifying container closure integrity.
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
![GettyImages-1325865279-patient-doctor]( "The Importance Of A Human Centered Approach To Product Development")
The Importance Of A Human Centered Approach To Product DevelopmentTo meet the needs of patients, life-saving device innovations are needed for the next generation of delivery devices. As drug manufacturers explore the device world, human factors are a key consideration.
-
![GettyImages-1337453095-doctor-patient]( "Off-The-Shelf Vs. Novel Devices: Selecting A Drug Delivery System")
Off-The-Shelf Vs. Novel Devices: Selecting A Drug Delivery SystemWhether bringing a novel therapy to market or altering current devices, companies must determine the best selection for administration without impacting drug efficacy, quality, and safety.
-
![GettyImages-1327620750-lab-research]( "The Role Of Micronization In The Journey To Drug Product Development")
The Role Of Micronization In The Journey To Drug Product DevelopmentMicronization is an incredibly important step of the process of transitioning a compound from initial discovery into the clinic. Learn more about the key benefits of micronization.
-
![adaptdose_adare_sized]( "Maintaining Drug Bioavailability And Masking Taste With Microencapsulation")
Maintaining Drug Bioavailability And Masking Taste With MicroencapsulationSeveral technologies are available for microencapsulating drugs. Finding the right CDMO to optimize a drug’s efficacy and manufacturing during formulation is integral to its clinical and commercial success.
-
![GettyImages-501743090_nasal spray]( "Key Considerations When Choosing A Device For Dry Powder Nasal Delivery")
Key Considerations When Choosing A Device For Dry Powder Nasal DeliveryBuilding on previous discussions, here we discuss the benefits of nasal delivery and the challenges of developing dry powder formulations by focusing on key devices that can be used for delivering dry powder nasal dosage forms.
-
![WEST-Labs 168_ViewingQuarter-0052]( "Containment Solutions To Help Emerging Biologic Companies")
Containment Solutions To Help Emerging Biologic CompaniesSet up your small company for long-term success using packaging containment offerings and services to help mitigate risks and speed up your time to market.
-
![West3]( "Taking A Best Practice Approach To Contamination Control")
Taking A Best Practice Approach To Contamination ControlImplementing the EU GMP Annex 1 requires a holistic, evolutionary Contamination Control Strategy built on standardization, data analytics, and continuous improvement for a zero-defect mindset.
-
![AI-Enhanced Drug Discovery-GettyImages-2196697516]( "Microphysiological Systems: Closing The Gap Between Models And Medicine")
Microphysiological Systems: Closing The Gap Between Models And MedicineMicrophysiological systems (MPS) use human cells to model tissue function, offering faster, more predictive insights for drug discovery, safety testing, and personalized medicine—bridging gaps left by animal and 2D models.
-
![DD 2 - 2mL_10mL_Vials_Tubs_Capped]( "Safeguarding Cell Therapy Cryopreservation: Primary Containers")
Safeguarding Cell Therapy Cryopreservation: Primary ContainersReview different aspects of container selection from the perspective of cryopreservation that are may be overlooked but critical for the quality of cell therapy drug products.
-
![West-NovaPure]( "Moving From Vial Systems To Prefilled Syringes And Autoinjector Systems")
Moving From Vial Systems To Prefilled Syringes And Autoinjector SystemsMoving from vial systems to prefilled syringes and autoinjector systems requires patient and caregiver needs, drug product requirements, system components, and performance.
TOM'S TAKES ON DRUG DELIVERY
TALKING WITH TOM VIDEOCASTS
Fran offers keen industry and technical insights exclusively on Drug Delivery Leader.
DELIVERED BY DEGRAZIO
-
![Delivered _by _DeGrazio_Logo_Color_2]( "Procuring Packaging And Delivery Systems: Single Versus Dual Sourcing")
Procuring Packaging And Delivery Systems: Single Versus Dual SourcingIn this article, Fran DeGrazio examines the trend toward dual sourcing of products, components, and materials for drug delivery packaging and systems. She outlines the key differences between single and dual sourcing and makes recommendations about using one versus the other while mitigating supply chain and product quality risk.
FREE EBOOK: COMBINATION PRODUCTS
Combination products provide significant avenues for increasing patient adherence and overall efficacy. This collection outlines the opportunity and identifies strategies for gaining regulatory approval.
